{"id":"cost-free-pharmacotherapy-group","safety":{"commonSideEffects":[{"rate":null,"effect":"None reported"}]},"_chembl":{"chemblId":"CHEMBL2108795","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This program involves a combination of education, support, and reminders to encourage patients to take their medications as prescribed. By addressing the root causes of non-adherence, such as lack of knowledge or forgetfulness, patients are more likely to stick to their treatment plans and achieve better health outcomes.","oneSentence":"Cost-Free Pharmacotherapy Group is a behavioral intervention that helps patients manage their medication adherence.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:31:25.594Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Atrial fibrillation for stroke prevention"},{"name":"Heart failure management"}]},"trialDetails":[{"nctId":"NCT06874790","phase":"NA","title":"RCT for Latina Mental Health Using Web-Based Apps","status":"RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2025-07-09","conditions":"Mental Health, Anxiety, Depression","enrollment":700},{"nctId":"NCT05299840","phase":"NA","title":"Impact of Using the Oncogramme® Device to Select the First Line of Treatment for Patients With Metastatic Colorectal Cancer","status":"RECRUITING","sponsor":"Oncomedics","startDate":"2023-06-07","conditions":"Metastatic Colorectal Cancer","enrollment":450},{"nctId":"NCT05384509","phase":"","title":"(COVID-19) Longitudinal Neutralizing Antibody Titers in Cancer Patients Receiving Different Anti-caner Therapies","status":"RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2021-12-01","conditions":"Cancer","enrollment":320},{"nctId":"NCT04920344","phase":"PHASE2","title":"Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy","status":"UNKNOWN","sponsor":"Rutgers, The State University of New Jersey","startDate":"2021-07-19","conditions":"Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8","enrollment":15},{"nctId":"NCT00962988","phase":"PHASE4","title":"Efficacy and Cost-Effectiveness of Cost-free Pharmacotherapy for Smoking Cessation for High-risk Smokers With Cerebrovascular Disease","status":"COMPLETED","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2009-12","conditions":"Cerebrovascular Disorders, Smoking Cessation","enrollment":194},{"nctId":"NCT05081115","phase":"","title":"Stress Echo 2030: the Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging","status":"RECRUITING","sponsor":"Fatebenefratelli Hospital","startDate":"2021-04-01","conditions":"Coronary Artery Disease, Heart Failure, Hypertrophic Cardiomyopathy","enrollment":10000},{"nctId":"NCT03877783","phase":"NA","title":"DEMAND - Multifactorial Study to Reduce Dementia in People With Type 2 Diabetes","status":"UNKNOWN","sponsor":"Umeå University","startDate":"2020-10-19","conditions":"Type 2 Diabetes Mellitus, Mild Cognitive Impairment","enrollment":10},{"nctId":"NCT01404546","phase":"NA","title":"Cost Free Pharmacotherapy for Smoking Cessation in Stroke Patients","status":"COMPLETED","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2008-08","conditions":"Stroke","enrollment":28}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Nicotine Patch","Champix","Chantix","Wellbutrin"],"phase":"marketed","status":"active","brandName":"Cost-Free Pharmacotherapy Group","genericName":"Cost-Free Pharmacotherapy Group","companyName":"Ottawa Heart Institute Research Corporation","companyId":"ottawa-heart-institute-research-corporation","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Cost-Free Pharmacotherapy Group is a behavioral intervention that helps patients manage their medication adherence. Used for Atrial fibrillation for stroke prevention, Heart failure management.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":2},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}